Literature DB >> 16838183

IgA nephropathy in two adolescent sisters heterozygous for Fabry disease.

Catharina Whybra1, Andreas Schwarting, Jörg Kriegsmann, Andreas Gal, Eugen Mengel, Christoph Kampmann, Frank Baehner, Ellen Schaefer, Michael Beck.   

Abstract

We report a 16-year-old girl and her one-year-younger sister, both heterozygous for the c.34del24 mutation of the GLA (alpha-galactosidase A) gene, which they inherited from their father who is affected by Fabry disease (FD). Both girls presented with macrohematuria and rapidly progressing proteinuria. Urine analysis revealed glomerular hematuria and a nephrotic range of proteinuria suggesting a concomitant glomerulonephritis. Light microscopy of kidney biopsy was characteristic of IgA nephropathy (IgA deposits in mesangial areas and glomerular capillary loops, and mesangial hypercellularity), whereas electron microscopy showed changes typical of Fabry disease (multiple osmiophilic inclusions in the subendothelial and mesangial areas). These two cases and similar reports in the literature suggest that IgA nephropathy in FD is not merely coincidental.

Entities:  

Mesh:

Year:  2006        PMID: 16838183     DOI: 10.1007/s00467-006-0176-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  28 in total

1.  Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females.

Authors:  K D MacDermot; A Holmes; A H Miners
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

2.  A characteristic dissection microscopy appearance of a renal biopsy of a Fabry heterozygote.

Authors:  N W Yuen; C W Lam; T C Chow; M C Chiu
Journal:  Nephron       Date:  1997       Impact factor: 2.847

3.  A 19-year-old female with fever, acroparesthesia, and progressive deterioration of renal function.

Authors:  M A el-Shahawy; C Mesa; M Koss; V M Campese
Journal:  Am J Nephrol       Date:  1996       Impact factor: 3.754

4.  A case of Fabry's disease with granulomatous interstitial nephritis.

Authors:  Y Hiraizumi; M Kanoh; H Shigematsu; M Yamashina; T Kondo
Journal:  Nihon Jinzo Gakkai Shi       Date:  1995-11

5.  Characterization of antibodies against ceramidetrihexoside and globoside.

Authors:  M N Hamers; W E Donker-Koopman; M J Coulon-Morelec; P Dupouey; J M Tager
Journal:  Immunochemistry       Date:  1978-06

6.  [Fabry nephropathy in a female with superposed IgA glomerulonephritis].

Authors:  A Pisani; A Sessa; M Sabbatini; M V Andreucci; C Fusco; M Balletta; B Cianciaruso
Journal:  G Ital Nefrol       Date:  2005 Jul-Aug

7.  The co-existence of Fabry and celiac diseases: a case report.

Authors:  Leyla Tümer; Fatih S Ezgü; Alev Hasanoğlu; Buket Dalgiç; Sevcan A Bakkaloğlu; Leyla Memiş; Ayşe Dursun
Journal:  Pediatr Nephrol       Date:  2004-04-15       Impact factor: 3.714

8.  Results of a nationwide screening for Anderson-Fabry disease among dialysis patients.

Authors:  Peter Kotanko; Reinhard Kramar; Danijela Devrnja; Eduard Paschke; Till Voigtländer; Martin Auinger; Severo Pagliardini; Marco Spada; Klaus Demmelbauer; Matthias Lorenz; Anna-Christine Hauser; Hans-Jörg Kofler; Karl Lhotta; Ulrich Neyer; Wolfgang Pronai; Manfred Wallner; Clemens Wieser; Martin Wiesholzer; Herbert Zodl; Manuela Födinger; Gere Sunder-Plassmann
Journal:  J Am Soc Nephrol       Date:  2004-05       Impact factor: 10.121

9.  [A case of Fabry's disease associated with lupus nephritis].

Authors:  K Majima; T Ishizaki; T Inoue; Y Hori; J Egami; A Oohara; H Nishida; Y Miyake; S Matsumoto; E Kinoshita
Journal:  Nihon Jinzo Gakkai Shi       Date:  1992-11

10.  Kidney involvement in systemic lupus erythematosus and Fabry's disease.

Authors:  E Rosenmann; I Kobrin; T Cohen
Journal:  Nephron       Date:  1983       Impact factor: 2.847

View more
  15 in total

1.  Antigen presenting cell abnormalities in the Cln3(-/-) mouse model of juvenile neuronal ceroid lipofuscinosis.

Authors:  Samantha L Hersrud; Attila D Kovács; David A Pearce
Journal:  Biochim Biophys Acta       Date:  2016-04-19

Review 2.  Lysosome dysfunction in the pathogenesis of kidney diseases.

Authors:  Kameswaran Surendran; Seasson P Vitiello; David A Pearce
Journal:  Pediatr Nephrol       Date:  2013-11-12       Impact factor: 3.714

3.  High incidence of autoantibodies in Fabry disease patients.

Authors:  P Martinez; M Aggio; P Rozenfeld
Journal:  J Inherit Metab Dis       Date:  2007-04-24       Impact factor: 4.982

4.  Kidney biopsy findings in heterozygous Fabry disease females with early nephropathy.

Authors:  Carmen Valbuena; Elísio Carvalho; Manuela Bustorff; Mariana Ganhão; Sandra Relvas; Rosete Nogueira; Fátima Carneiro; João Paulo Oliveira
Journal:  Virchows Arch       Date:  2008-09-04       Impact factor: 4.064

5.  Agalsidase alfa (Replagal) in the treatment of Anderson-Fabry disease.

Authors:  Gregory M Pastores
Journal:  Biologics       Date:  2007-09

6.  Coexistence of Fabry disease and IgA nephropathy: a report of two cases.

Authors:  G Yin; Y Wu; C-H Zeng; H-P Chen; Z-H Liu
Journal:  Ir J Med Sci       Date:  2014-06-10       Impact factor: 1.568

7.  Leukocyte perturbation associated with Fabry disease.

Authors:  P Rozenfeld; E Agriello; N De Francesco; P Martinez; C Fossati
Journal:  J Inherit Metab Dis       Date:  2009-03-07       Impact factor: 4.982

8.  Screening for Fabry Disease in Patients With Juvenile Systemic Lupus Erythematosus.

Authors:  Ertugrul Kiykim; Sezgin Şahİn; Tanyel ZubarioĞlu; Kenan Barut; Amra Adrovic; Mehmet Şerif Cansever; Ayşe Çiğdem AktuĞlu Zeybek; Özgür KasapÇopur
Journal:  Arch Rheumatol       Date:  2020-02-07       Impact factor: 1.472

9.  Carboxyl-terminal truncations alter the activity of the human α-galactosidase A.

Authors:  Mariam Meghdari; Nicholas Gao; Abass Abdullahi; Erin Stokes; David H Calhoun
Journal:  PLoS One       Date:  2015-02-26       Impact factor: 3.240

10.  The coincidence of IgA nephropathy and Fabry disease.

Authors:  Dita Maixnerová; Vladimír Tesař; Romana Ryšavá; Jana Reiterová; Helena Poupětová; Lenka Dvořáková; Lubor Goláň; Michaela Neprašová; Jana Kidorová; Miroslav Merta; Eva Honsová
Journal:  BMC Nephrol       Date:  2013-01-11       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.